20. toukokuuta
Activia-tutkimukset
Danonen terveysvaikutteisten jogurttien merkittävimmät probioottibakteerit kuuluvat Bifidus- ja Lactobasillicus-sukuihin. Bifidobacterium lactis DN-173010:lla (Activia) ja Lactobacillus casei DN-114001:lla (Actimel) on tehty useita prekliinisiä ja kliinisiä tutkimuksia.
Terveysväittämien validoimiseksi Danonen kliiniset tutkimukset tehdään aina lopullisella tuotteella ja lopullisessa tuotteessa olevalla bakteerimäärällä.
|
Guyonnet D, Schlumberger A, Mhamdi L, Jakob S, Chassany O. Danone Research, Palaiseau, France. |
Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study. |
|
|
Guyonnet D., Woodcock A., Stefani B., Trevisan C. and Hall C. Danone Research, Palaiseau Cedex |
Fermented milk containing Bifidobacterium lactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults. A randomized, open-label, controlled, pilot study. |
|
|
Agrawal A., Houghton L.A., Morris J., Reilly B.,D., Guyonnet D., Goupil-Feuillerat N., Schlumberger A., Jakob S. & Whorwell P.J. Neurogastroenterology Unit, Translational Medicine - GI Sciences, University of Manchester, Wythenshawe Hospital |
Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. |
Alimentary Pharmacology and Therapeutics, 2009; 29(1): 104-114. |
|
Yang Y., He M., Hu G., Wei J., Pages P., Yang X., Bourdu-Naturel S. Institute of Nutrition and Food Safety, China CDC |
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on Chinese constipated women. |
|
|
Rochet V, L Rigottier-Gois, A Ledaire, C Andrieux, M Sutren, S Rabot, A Mogenet, J-L Bresson, S Cools, C Picard, N Goupil-Feuillerat and J Doré Unité d'Ecologie et Physiologie du Système Digestif, Institut National de la Recherche Agronomique |
Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product - a randomised study in healthy adults. |
Journal of Molecular Microbiology and Biotechnology, 2008;14: 128-136. |
|
He T, M G Priebe, Y Zhong, C Huang, HJM Harmsen, GC Raangs, JM Antoine, GW Welling and RJ Vonk Center for Medical Biomics, University Medical Center Groningen, University of Groningen |
Effect of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. |
|
|
Guyonnet D, O. Chassany, P. Ducrotte, C. Picard, M. Mouret, C.H. Mercier and C. Matuchansky Danone Research, Palaiseau |
Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel symdrome adults in primary care. A multicentre, randomised, double-blind, controlled trial. |
Alimentary Pharmacology and Therapeutics, 2007; 26 (3): 475-486. |
|
Marteau P, Cuillerier E, Méance S, Gerhardt MF, Myara A, Bouvier M, Bouley C, Tondu F, Bommelaer G, Grimaud JC Gastroenterology Department, European Hospital Georges Pompidou |
Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women : a double blind, randomized, controlled study. |
|
|
Pochart P, Marteau P, Bouhnik Y, Goderet I, Bourlioux P, Rambaud JC INSERM U290, Hôpital Saint-Lazare |
Survival of Bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. |
|
|
Berrada N, Lemeland JF, Laroche G, Thouvenot P, Piaia M Service d'Hépato-Gastroentérologie, Hôpital Charles-Nicolle |
Bifidobacterium from fermented milks: Survival during gastric transit. |
Tutkimusrahoitus
Lupaavan tutkimustyön tukeminen on yksi keskeisimmistä tavoista, joilla edistämme tietämystä ruokavalion, ravinnon ja terveyden keskinäisistä suhteista.
